ProQR Therapeutics N.V. Ordinary Shares (PRQR)
ProQR Therapeutics N.V. Ordinary Shares
XNAS:PRQR
2.19
$2.21 - 2.00
$2.19 - 619.00
$2.19
$2.35
$2.35
$2.34
3.97
1.07
57105
325251.3
70020934.91
Chart
TendieTensor AI Analysis
Company
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
Fundamentals
166
-5.120000
3.676010
-0.1
100
105.21M
105.34M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own PRQR. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.